Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older

Purpose: The present study aimed to evaluate the oncologic outcomes of patients 80 years or older compared with younger patients, and we then further investigated the efficacy of chemotherapy in individuals 80 years or older.Methods: A retrospective analysis was conducted using the Surveillance, Epi...

Full description

Bibliographic Details
Main Authors: Wenting Liu, Mengyuan Zhang, Jun Wu, Ran Tang, Liqun Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.525421/full
id doaj-5af2b88f9de04d059100493bfddd882e
record_format Article
spelling doaj-5af2b88f9de04d059100493bfddd882e2020-11-25T03:05:58ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-10-01710.3389/fmed.2020.525421525421Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or OlderWenting Liu0Mengyuan Zhang1Jun Wu2Ran Tang3Liqun Hu4Geriatric Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, ChinaGeriatric Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, ChinaGeriatric Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, ChinaDepartment of Pediatric Surgery, Anhui Provincial Children's Hospital, Hefei, ChinaGeriatric Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, ChinaPurpose: The present study aimed to evaluate the oncologic outcomes of patients 80 years or older compared with younger patients, and we then further investigated the efficacy of chemotherapy in individuals 80 years or older.Methods: A retrospective analysis was conducted using the Surveillance, Epidemiology and End Results database. The χ2 test was used to analyze the different clinicopathologic and demographic variables between 65- and 79-year and ≥80-year groups. Kaplan–Meier analysis and log-rank testing were used to compare colorectal cancer (CRC)–specific survival (CCSS) curves between different groups. Multivariate and univariate Cox proportional hazards models with hazard ratios (HRs) and 95% confidence intervals (CIs) were also used to assess CCSS and OS.Results: A total of 189,926 patients were included in our study. Compared with 65- to 79-year-old patients, age 80 years or older was associated with 48.4% increased CRC-specific mortality (HR = 1.484, 95% CI = 1.453–1.516, P < 0.0001; using 65–79 years old as the reference). Moreover, not receiving chemotherapy was significantly associated with an increased risk of CRC-related death, independent of other prognostic factors (HR = 0.615, 95% CI = 0.589–0.643, P < 0.0001) in individuals 80 years or older.Conclusions: This large population-based study showed that older age was associated with worse oncologic outcomes compared to younger age. Chemotherapy could offer survival benefit for very old patients diagnosed with CRC, and we strongly believed that very old patients were undertreated in the present medical practices.https://www.frontiersin.org/articles/10.3389/fmed.2020.525421/fullcolorectal cancerchemotherapy80 yearspopulation-basedsurvival
collection DOAJ
language English
format Article
sources DOAJ
author Wenting Liu
Mengyuan Zhang
Jun Wu
Ran Tang
Liqun Hu
spellingShingle Wenting Liu
Mengyuan Zhang
Jun Wu
Ran Tang
Liqun Hu
Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older
Frontiers in Medicine
colorectal cancer
chemotherapy
80 years
population-based
survival
author_facet Wenting Liu
Mengyuan Zhang
Jun Wu
Ran Tang
Liqun Hu
author_sort Wenting Liu
title Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older
title_short Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older
title_full Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older
title_fullStr Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older
title_full_unstemmed Oncologic Outcome and Efficacy of Chemotherapy in Colorectal Cancer Patients Aged 80 Years or Older
title_sort oncologic outcome and efficacy of chemotherapy in colorectal cancer patients aged 80 years or older
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2020-10-01
description Purpose: The present study aimed to evaluate the oncologic outcomes of patients 80 years or older compared with younger patients, and we then further investigated the efficacy of chemotherapy in individuals 80 years or older.Methods: A retrospective analysis was conducted using the Surveillance, Epidemiology and End Results database. The χ2 test was used to analyze the different clinicopathologic and demographic variables between 65- and 79-year and ≥80-year groups. Kaplan–Meier analysis and log-rank testing were used to compare colorectal cancer (CRC)–specific survival (CCSS) curves between different groups. Multivariate and univariate Cox proportional hazards models with hazard ratios (HRs) and 95% confidence intervals (CIs) were also used to assess CCSS and OS.Results: A total of 189,926 patients were included in our study. Compared with 65- to 79-year-old patients, age 80 years or older was associated with 48.4% increased CRC-specific mortality (HR = 1.484, 95% CI = 1.453–1.516, P < 0.0001; using 65–79 years old as the reference). Moreover, not receiving chemotherapy was significantly associated with an increased risk of CRC-related death, independent of other prognostic factors (HR = 0.615, 95% CI = 0.589–0.643, P < 0.0001) in individuals 80 years or older.Conclusions: This large population-based study showed that older age was associated with worse oncologic outcomes compared to younger age. Chemotherapy could offer survival benefit for very old patients diagnosed with CRC, and we strongly believed that very old patients were undertreated in the present medical practices.
topic colorectal cancer
chemotherapy
80 years
population-based
survival
url https://www.frontiersin.org/articles/10.3389/fmed.2020.525421/full
work_keys_str_mv AT wentingliu oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder
AT mengyuanzhang oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder
AT junwu oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder
AT rantang oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder
AT liqunhu oncologicoutcomeandefficacyofchemotherapyincolorectalcancerpatientsaged80yearsorolder
_version_ 1724676172322701312